ブース番号3H-32
カテゴリー原料
InnoPharmax, Inc
小間番号：3H-32
カテゴリー：原料
企業情報
Email：
jason.hsu@innopharmax.com
TEL：
住所： 9F., No.22, Lane 478, Rueiguang Rd. Neihu District, Taipei
URL：
http://www.innopharmax.com
InnoPharmax is a clinical-stage pharmaceutical company (TPEx: 4172) focused on development and commercialization of oral new dosage form products, utilizing proprietary drug delivery technology platforms such as OralPAS®. We are committed to improve the safety and efficacy of currently available drugs, and provide superior and cost-effective medical options.
Business Development:
Our main focus is on 505(b)(2) Assets for licensing and co-development in Oncology, Diabetes, Hypertension, etc. We are also seeking clients and distribution partnerships for a variety of API and finished dosage form (FDF) products.
Business Development:
Our main focus is on 505(b)(2) Assets for licensing and co-development in Oncology, Diabetes, Hypertension, etc. We are also seeking clients and distribution partnerships for a variety of API and finished dosage form (FDF) products.
企業情報
| 住所 | 9F., No.22, Lane 478, Rueiguang Rd. Neihu District, Taipei |
|---|---|
| URL | http://www.innopharmax.com |
| jason.hsu@innopharmax.com |
| 出展製品・サービス |
D07001 GemOral (oral gemcitabine) BendaReady (Bendamustine HCl Injection RTD) N11005 Oral Insulin INNO-029 Riociguat CR INNO-027 Oral Teriparatide INNO-030 Oral Octreotide Sapropterin dihydrochloride API Gadopentetate Dimeglumine API Gadoterate Meglumine API |
|---|
出展製品・サービス
D07001 GemOral (oral gemcitabine)BendaReady (Bendamustine HCl Injection RTD)N11005 Oral InsulinINNO-029 Riociguat CRINNO-027 Oral TeriparatideINNO-030 Oral OctreotideSapropterin dihydrochloride APIGadopentetate Dimeglumine APIGadoterate Meglumine API